The report indicated the presence of thyroid papillary cancer in the central biopsy, but were inconclusive for the thyroid node and the level IV node. Total thyroidectomy with modified radical ...

The combination of savolitinib and durvalumab demonstrated durable activity in a phase 2 trial of patients with papillary RCC.

Metastatic papillary renal cancer has poor outcomes, and new treatments are needed. There is a strong rationale for investigating the combination of mesenchymal epithelial transition receptor (MET) ...

The following is a summary of “Therapeutic outcomes and safety of radiofrequency ablation for primary papillary thyroid ...